Wixela Inhub

Active Ingredient(s): Fluticasone Propionate + Salmeterol Xinafoate
FDA Approved: * January 30, 2019
Pharm Company: * MYLAN PHARMS INC
Category: Asthma

Fluticasone/salmeterol, sold under the brand name Advair among others, is a combination medication containing fluticasone propionate and salmeterol.[1] It is used in the management of asthma and chronic obstructive pulmonary disease (COPD).[1] It is used by inhaling the medication into the lungs.[1] Common side effects include thrush, headache, and cough.[2] Serious side effects may include worsening asthma, anaphylaxis, seizures... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Wixela Inhub Respiratory (Inhalation) Powder
NDC: 0378-9320
Labeler:
Mylan Pharmaceuticals Inc.
Wixela Inhub Respiratory (Inhalation) Powder
NDC: 0378-9321
Labeler:
Mylan Pharmaceuticals Inc.
Wixela Inhub Respiratory (Inhalation) Powder
NDC: 0378-9322
Labeler:
Mylan Pharmaceuticals Inc.
Wixela Inhub Respiratory (Inhalation) Powder
NDC: 70518-2501
Labeler:
Remedyrepack Inc.

Related Brands

Drugs with the same active ingredients